Cargando…
HSP90 and Its Novel Co-Chaperones, SGT1 and CHP-1, in Brain of Patients with Parkinson’s Disease and Dementia with Lewy Bodies
BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the presence of inclusions known as Lewy bodies in some brain regions. Lewy bodies consist of α-synuclein and many other proteins including chaperones. OBJECTIVE: To learn more about the role of chaperone complexes...
Autores principales: | Bohush, Anastasiia, Niewiadomska, Grażyna, Weis, Serge, Filipek, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398563/ https://www.ncbi.nlm.nih.gov/pubmed/30741686 http://dx.doi.org/10.3233/JPD-181443 |
Ejemplares similares
-
Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases
por: Bohush, Anastasiia, et al.
Publicado: (2019) -
HSP90 Co-Chaperone, CacyBP/SIP, Protects α-Synuclein from Aggregation
por: Bohush, Anastasiia, et al.
Publicado: (2020) -
Role of Mitogen Activated Protein Kinase Signaling in Parkinson’s Disease
por: Bohush, Anastasiia, et al.
Publicado: (2018) -
Sgt1 Regulates α-Synuclein Subcellular Localization and Expression of Parkinson’s Disease Related Genes, PINK1 and PARK9
por: Bohush, Anastasiia, et al.
Publicado: (2021) -
The Hsp90 Co-Chaperone Sgt1 Governs Candida albicans Morphogenesis and Drug Resistance
por: Shapiro, Rebecca S., et al.
Publicado: (2012)